Arquivos de tags: unless

Newborn infection trial ‘will fail’ unless Government intervenes, Especialistas dizem

Newborn infection trial ‘will fail’ unless Government intervenes, Especialistas dizem
Two babies on average develop Group B Strep infection in the UK every day.

A clinical trial to test pregnant women for group B Strep – the most common cause of life-threatening infection in newborn babies – will fail unless the Governo intervenes, experts have warned.

Algum 80 hospitals are needed for the trial to go ahead but only 32 have committed to it, with a deadline for registering of September.

The trial is being funded by the National Institute for Health Research and will look at whether testing women for group B Strep reduces the risk of babies dying or suffering harm.

Now Dr Jane Plumb, chief executive of Group B Strep Support, who lost her son Theo to the infection, is calling on the Government and NHS Inglaterra to intervene to make sure the trial goes ahead.

Ela disse: “The reality is that unless a further 48 hospitals sign up for this trial, then it will fail.

There seems to be little acknowledgement that this trial is heading towards failure

Jane Plumb, Group B Strep Support

“The Government is waiting for the results from this trial to determine whether to test pregnant women for group B Strep.

“Yet there seems to be little acknowledgement that this trial is heading towards failure.

“We need more hospitals on board and we need to make sure that the investment in this trial is not wasted.

“This is about saving the lives of babies, and it really is now or never.”

Olympian Iwan Thomas’s son Teddy fell ill with group B Strep and he is calling for the trial to go ahead
Olympian Iwan Thomas’s son Teddy fell ill with group B Strep and he is calling for the trial to go ahead

According to the charity, several local MPs have contacted hospitals themselves, after being urged to do so by the public.

Dr Plumb said: “We’re all interested in the results, but unless enough hospitals take part, the trial will fail.

“What is the Government and the NHS doing to ensure this trial is a success?”

According to the charity, the excess treatment cost threshold – the amount a trust has to put into research before they start getting reimbursed – has also been reduced, meaning cost should not be stopping trusts from signing up.

Data shows that two babies on average develop GBS infection in the UK every day, leading to one death a week and one baby left with long-term disabilities.

Many other countries, including the US, already screen for the infection.

The new trial – called GBS3 – is being led by researchers at the University of Nottingham.

This trial and the results are vital in stemming the rising tide of GBS infection in UK babies

Dr Carol Baker

It will look at whether testing reduces the risk of infection in newborn babies compared to the current strategy in place in the UK.

The current strategy is to offer antibiotics during labour to women who are considered at increased risk of their baby developing a group B Strep infection.

Two different tests will be examined – a lab-based test three to five weeks before a woman’s due date and a bedside test at the start of labour.

Dr Carol Baker, whose work led to universal GBS testing being introduced in the US, disse: “The US introduced routine testing for group B Strep for all pregnant women 20 anos atrás, and the rates of early-onset group B Strep infection in babies subsequently fell by over 80%.

“Other countries have seen similar declines but UK rates are increasing.

“This trial and the results are vital in stemming the rising tide of GBS infection in UK babies.”

Olympic runner Iwan Thomas MBE, whose first child Teddy feel ill with group B, disse: “Watching Teddy covered in tubes and fighting for his life in intensive care was by far the worst experience of my life.

“Fortunately, Teddy’s made a great recovery from his group B Strep infection, but I know there are those less fortunate whose children have died or survived with life-changing disabilities.

“That’s why I’m so passionate about the GBS3 trial succeeding, so other families don’t have to go through what I and so many others have.

“It’s outrageous that in 2022 babies are getting sick and dying from a preventable infection.”

The Department of Health and Social Care and NHS England have been approached for comment.